Mendra
Mendra is an AI-native biopharma company focused on developing breakthrough medicines for rare and ultra-rare pediatric diseases. It partners with R&D-stage biotech companies to accelerate clinical development and commercialization, handling regulatory, clinical, and reimbursement strategy while prioritizing the needs of patients and families. Founded by a team with experience from BioMarin, Palantir, and other pharma and biotech companies, Mendra launched with an $82 million Series A round and is backed by 8VC and Wing Venture Capital. The company operates a corporate marketing website and publishes no public API, developer portal, SDK, or technical documentation.
Mendra is profiled on the APIs.io network. Tagged areas include Company, Biopharma, Rare Diseases, Pharmaceuticals, and Artificial Intelligence.
Kin Score
Resources
Company 1
The organization behind the API